=== PAGE 5 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
John F. Weet, PhD                                                               Page 5
Collegium Pharmaceuticals, Inc.
NDA 208090 MA 114


The violations discussed in this letter do not necessarily constitute an exhaustive list. It is
your responsibility to ensure that your promotional materials for Xtampza ER comply with
each applicable requirement of the FD&C Act and FDA implementing regulations.


                                                              Sincerely,

                                      {See appended electronic signature page}

                                      Koung Lee, RPh, MSHS
                                      Regulatory Review Officer
                                      Division of Advertising & Promotion Review 1
                                      Office of Prescription Drug Promotion

                                      {See appended electronic signature page}

                                      Samuel Skariah, PharmD, RAC
                                      Team Leader
                                      Division of Advertising & Promotion Review 1
                                      Office of Prescription Drug Promotion




Reference ID: 4219942
